Waystar (NASDAQ:WAY) Receives New Coverage from Analysts at Barclays

Research analysts at Barclays began coverage on shares of Waystar (NASDAQ:WAY) in a report released on Tuesday, MarketBeat.com reports. The firm set an “overweight” rating and a $24.00 price target on the stock. Barclays‘s target price would indicate a potential upside of 11.63% from the stock’s current price.

Other equities research analysts have also issued research reports about the company. Deutsche Bank Aktiengesellschaft started coverage on Waystar in a research report on Tuesday. They set a “buy” rating and a $27.00 target price on the stock. Canaccord Genuity Group began coverage on Waystar in a report on Tuesday. They set a “buy” rating and a $30.00 price target on the stock. The Goldman Sachs Group assumed coverage on shares of Waystar in a research note on Tuesday. They issued a “buy” rating and a $32.00 price objective for the company. Evercore ISI began coverage on shares of Waystar in a research note on Tuesday. They set an “outperform” rating and a $25.00 target price on the stock. Finally, Royal Bank of Canada assumed coverage on shares of Waystar in a research note on Tuesday. They issued an “outperform” rating and a $27.00 price target for the company. Eleven equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $27.60.

Waystar Stock Down 0.0 %

Shares of WAY opened at $21.50 on Tuesday. Waystar has a 12 month low of $20.50 and a 12 month high of $23.09.

About Waystar

Waystar Holding Corp. is a software company which provide healthcare payments. Waystar Holding Corp. is based in LEHI, Utah.